Literature DB >> 4017223

A sensitive fluorometric assay for serum monoamine oxidase with kynuramine as substrate.

T Matsumoto, O Suzuki, T Furuta, M Asai, Y Kurokawa, Y Nimura, Y Katsumata, I Takahashi.   

Abstract

The detailed procedure of a new sensitive fluorometric assay for human serum monoamine oxidase (MAO) with kynuramine as substrate is described. The data on its reproducibility, stability, correlation with another method, and serum MAO levels for 150 healthy subjects and 205 patients with various diseases, are presented to support the usefulness of this method. Since our method is much simpler and more sensitive than other methods conventionally used, we can recommend it for routine clinical investigation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4017223     DOI: 10.1016/s0009-9120(85)80094-1

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  Selegiline reverses aβ₂₅₋₃₅-induced cognitive deficit in male mice.

Authors:  Andréia M Pazini; Guilherme M Gomes; Jardel G Villarinho; Claudio da Cunha; Francielle Pinheiro; Ana P O Ferreira; Carlos F Mello; Juliano Ferreira; Maribel A Rubin
Journal:  Neurochem Res       Date:  2013-09-05       Impact factor: 3.996

Review 2.  On the practical aspects of characterising monoamine oxidase inhibition in vitro.

Authors:  Andrew Holt
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

Review 3.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

4.  Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.

Authors:  Danúbia Bonfanti Santos; Dirleise Colle; Eduardo Luiz Gasnhar Moreira; Mariana Appel Hort; Marcelo Godoi; Gael Le Douaron; Antonio Luiz Braga; Jamil Assreuy; Patrick Pierre Michel; Rui Daniel Prediger; Rita Raisman-Vozari; Marcelo Farina
Journal:  Mol Neurobiol       Date:  2016-02-06       Impact factor: 5.590

5.  Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.

Authors:  Eduardo L G Moreira; Daniel Rial; Aderbal S Aguiar; Cláudia P Figueiredo; Jarbas M Siqueira; Silvia DalBó; Heros Horst; Jade de Oliveira; Gianni Mancini; Tiago S dos Santos; Jardel G Villarinho; Francielle V Pinheiro; José Marino-Neto; Juliano Ferreira; Andreza F De Bem; Alexandra Latini; Moacir G Pizzolatti; Rosa M Ribeiro-do-Valle; Rui D S Prediger
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

6.  Antidepressant-like effect of Campomanesia xanthocarpa seeds in mice: Involvement of the monoaminergic system.

Authors:  Gabriela Sabrina Anzollin; Lilian Zaki; Thalita Maria Perin; Bruna Finger; Letícia Trentin Perin; Fernanda Petry; Thalia Sebulsqui Saraiva; Maria Luiza Lima da Costa Lopes; Andresa Heemann Betti; Jaqueline Scapinello; J Vladimir Oliveira; Jacir Dal Magro; Liz G Müller
Journal:  J Tradit Complement Med       Date:  2021-08-30

Review 7.  Selective MAO-B inhibitors: a lesson from natural products.

Authors:  Simone Carradori; Melissa D'Ascenzio; Paola Chimenti; Daniela Secci; Adriana Bolasco
Journal:  Mol Divers       Date:  2013-11-12       Impact factor: 2.943

8.  Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors.

Authors:  Gülhan Turan-Zitouni; Weiam Hussein; Begüm Nurpelin Sağlık; Aouatef Tabbi; Büşra Korkut
Journal:  Molecules       Date:  2018-01-08       Impact factor: 4.411

9.  Pharmacological and Toxicological Screening of Novel Benzimidazole-Morpholine Derivatives as Dual-Acting Inhibitors.

Authors:  Nafiz Öncü Can; Ulviye Acar Çevik; Begüm Nurpelin Sağlık; Yusuf Özkay; Özlem Atlı; Merve Baysal; Ümide Demir Özkay; Özgür Devrim Can
Journal:  Molecules       Date:  2017-08-19       Impact factor: 4.411

10.  Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors.

Authors:  Betül Kaya; Leyla Yurttaş; Begüm Nurpelin Sağlik; Serkan Levent; Yusuf Özkay; Zafer Asim Kaplancikli
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.